Stifel Financial
ENZ

Stifel Financial’s Enzo Biochem, Inc. ENZ Stock Holding History

Stifel Financial’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-13,191
Closed -$42K – 2405
2015
Q3 		$42K Buy
+13,191
New +$40K ﹤0.01% 2190

Other funds holding ENZ

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
LSVM
Lone Star Value Management Old Greenwich, Connecticut $52.7M AUM 30.18% 1-Year Est. Return
KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return

Stifel Financial's ENZ Position: Q4 2015 in Review

Stifel Financial sold out of Enzo Biochem, Inc. (ENZ) in Q4 2015, closing a stake of 13,191 shares — an estimated $42K sold.

Stifel Financial first reported a position in ENZ in Q3 2015 and held it in 1 quarter. The position peaked at $42K in Q3 2015. 89 funds tracked by Wall St. Rank hold ENZ as of Q4 2015.

  • Stifel Financial reported no remaining Enzo Biochem, Inc. position as of Q4 2015 after selling out during the quarter.
  • Stifel Financial sold 13,191 Enzo Biochem, Inc. shares in Q4 2015, an estimated $42K.
  • Stifel Financial first reported a position in Enzo Biochem, Inc. in Q3 2015 and held it in 1 quarter.
  • Stifel Financial's Enzo Biochem, Inc. position peaked at $42K in Q3 2015.
  • 89 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2015.

Based on Stifel Financial's 13F filing for Q4 2015, filed 16 Feb 2016.